Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

NCT00192140 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
345
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

MedImmune LLC